Clinical trials for Cancer in United States

HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma

Study ID: NCT04903080

Sponsor

Pediatric Brain Tumor Consortium

Phase I Human Analytics (HALO) Study

Study ID: NCT05423860

Sponsor

HALO Diagnostics

Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic

Study ID: NCT06329531

Sponsor

M.D. Anderson Cancer Center

Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial

Study ID: NCT06593431

Sponsor

M.D. Anderson Cancer Center

Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen Insensitivity

Study ID: NCT04708431

Sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

Study ID: NCT06263231

Sponsor

Intensity Therapeutics, Inc.

A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC

Study ID: NCT05394831

Sponsor

I INTS BIO

Study of Personalized Cancer Therapy to Determine Response and Toxicity

Study ID: NCT02478931

Sponsor

Species name

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Study ID: NCT05797831

Sponsor

Kartos Therapeutics, Inc.

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Study ID: NCT06918431

Sponsor

City of Hope Medical Center